Cannabiz
Google AI
Medicinal cannabis giant Montu faces serious allegations of deleting crucial documents during the discovery phase of its ongoing legal battle with Australia’s Therapeutic Goods Administration (TGA). [1]
Lawyers for the health regulator claim that Montu erased, or allowed others to erase, essential evidence from internal business communication networks. The dynamic of this major compliance clash involves several key developments. [1]
The Deletion Allegations
Lawyers acting for the regulator claim that Montu wiped data from the business messaging app Slack and the digital whiteboard tool Miro. According to legal teams, it appears this material disappeared after the official TGA court proceedings had already been launched. The regulator calls these missing records a series of “alleged deficiencies” in how Montu is handling court-ordered document sharing. [1]
The Core Advertising Case
The underlying case began in April 2024 when the TGA filed an official lawsuit in the Federal Court of Australia against Montu Group, its clinic brand Alternaleaf, and director Christopher Strauch. [1]
- The Charges: Montu faces 226 alleged offenses for the unlawful advertising of prescription-only medicinal cannabis to the general public. [1, 2]
- The Tactics: The regulator claims Montu used restricted terms like “medical cannabis” and “plant medicine” on websites and social media to drive patients to its online telehealth booking portal. [1]
- The Scope: The lawsuit also covers banned public promotions, including a light projection stunt in Sydney and marketing websites spun up for awareness weeks. [1]
Next Steps in Court
Montu has publicly rejected the claims and stated it intends to “vigorously defend” its business practices. However, this latest document-tampering accusation adds significant friction to an already massive trial. The Federal Court of Victoria has locked in a seven-day trial in Melbourne to rule on the matter. Due to the scale of the evidence and these emerging discovery issues, legal representatives indicate the litigation could potentially stretch out for quite some time. [1, 2, 3, 4, 5]
If you would like to follow this unfolding trial closer, would you like me to look up the exact dates of the upcoming hearings or compile a summary of how Australia regulates prescription drug advertising?
The Case
Published
